Single Use Assemblies Is Predicted to Skyrocket at A CAGR of 24% By 2032

As per the new industry analysis by Fact.MR, a market research and competitive intelligence provider, the global single use assemblies market is currently valued at US$ 3 billion and is forecasted to surge ahead at 24% CAGR through 2032.

The cost and time required to clean stainless steel is something that life science businesses are eager to avoid. A growing environment has been provided by the rapid global biotech industry growth, where unique, disposable technologies are taking on increasing importance.

Download Sample Copy of This Report :-

https://www.factmr.com/connectus/sample?flag=S&rep_id=7816

The pharmaceutical business will expand at a quicker rate over the coming years as pharmaceutical firms, distributors, CMOs, and manufacturers unite to benefit from the advantages of single-use assemblies.

The significance of single-use technology in advancing cutting-edge research into various ailments, including cancer research and medicines for rare diseases, is expected to rise, spurring the demand for single use assemblies. Over the decade, the expanding biologics market will also create profitable opportunities for the manufacturers of single use assemblies.

The main problem facing manufacturers is eliminating the possibility of contamination, which now entails the high-level monitoring of crucial manufacturing processes. By removing or drastically lowering the need for sterilizing between batches, single-use assemblies assist manufacturers in overcoming this challenge and increasing their operating capability.

Segments of Single Use Assemblies Industry Research

• By Product :

o Bag Assemblies
o Filtration Assemblies
o Bottle Assemblies
o Mixing System Assemblies

• By Application :

o Filtration
o Cell Culture & Mixing
o Storage
o Sampling
o Fill-finish Application

Looking for A customization report click here:

https://www.factmr.com/connectus/sample?flag=RC&rep_id=7816

• By End User :

o Biopharma & Pharma Companies
o CROs & CMOs
o Academic & Research Institutes

• By Region :

o North America
o Latin America
o Europe
o East Asia
o South Asia & Oceania
o MEA

As many biopharmaceutical firms venture into disposable assembly offerings for the production of various types of biopharmaceuticals, single use technologies (SUTs) are regarded as one of the key areas of development among biomanufacturing companies. Additionally, SUTs are widely used in commercial manufacturing facilities for the production of biopharmaceuticals that are meant for clinical trials. Due to the requirement for utilities, which produce steam, water, and clean-in-place solutions, SUTs enable biologics manufacturers to lower the facilities' footprint by about 20%.

• According to studies by BioProcess International, engineers predicted that the single-use facility's capital cost will be 25%-45% lower than a facility built with stainless-steel equipment.

• In a similar vein, they predicted that single-use facilities could be constructed in 18 months and would use half as much water and energy to operate, whereas, stainless steel facilities need three years to complete.

Key Takeaways from Market Study

• Global sales of single use assemblies are expected to surge at a CAGR of 24% from 2022 to 2032.
• The global market for single use assemblies is projected to reach US$ 25.8 billion by 2032.
• China's market is predicted to expand at a massive CAGR of 30.5% during the forecast period (2022-2032).
• Sales of bag assemblies are likely to increase at an impressive CAGR of 29% from 2022 to 2032.

"Rising cases of chronic disorders has increased the demand for single use assemblies such as tubing assemblies and sterile bags," says a Fact.MR analyst.

Winning Strategy

Key suppliers of single use assemblies are Sartorius AG, Danaher Corporation, Thermo Fisher Scientific, GE Healthcare, Parker Hannifin Corporation, Merck KGaA, Avantor Inc, and Saint-Gobain.

• The joint venture (JV) established by Pall and Austar, Pall-Austar Lifesciences Limited, was fully acquired by Pall Corporation in March 2021. This acquisition will boost production capacity to meet China's supply chain need for single-use technology, which is being driven by COVID-19.

Get Free Access of Complete Report:

https://www.factmr.com/checkout/7816

Key Companies Profiled

• Avantor
• Charter Medical
• Colder Products Company
• Cole Parmer
• Corning
• Danaher
• Entegris
• Flexbiosys
• Foxx Life Sciences
• GE Healthcare
• Intellitech
• Keofitt
• Lonza
• Meissner
• Merck Millipore

More Valuable Insights on Offer

Fact.MR, in its new offering, presents an unbiased analysis of the global single use assemblies market, presenting historical demand data (2017-2021) and forecast statistics for the period of 2022-2032.

The study divulges essential insights on the market on the basis of product (bag assemblies, filtration assemblies, bottle assemblies, mixing system assemblies, others), application (filtration, cell culture & mixing, storage, sampling, fill-finish application, others), and end user (biopharma & pharma companies, CROs & CMOs, academic & research institutes), across five major regions of the world (North America, Europe, Asia Pacific, Latin America, and MEA).

Read More Trending Reports of Fact.MR :

https://www.prnewswire.com/news-releases/anesthesia-monitoring-devices-market-to-exceed-us-3-4-billion-by-2027-amid-rising-prevalence-of-degenerative-and-chronic-illnesses-301659609.html

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E Mail : sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

About Fact.MR

Market research and consulting agency with a difference! That's why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range - from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we'll be an able research partner.

This release was published on openPR.